# MayMag Biologics

> MayMag Biologics is a US-based 506(e) large-scale pharmaceutical manufacturer and CDMO specialising in biosimilar biologics, GLP-1 peptide synthesis (tirzepatide, semaglutide analogues), insulin pens, sterile injectables, and bacteriostatic water for commercial distributors and healthcare systems. GMP-certified facilities in Dallas and Garland, Texas.

## Pages
- [Home](https://maymagbiologics.com/)
- [Products](https://maymagbiologics.com/products)
- [Blog](https://maymagbiologics.com/blog)
- [About](https://maymagbiologics.com/about)
- [Contact](https://maymagbiologics.com/contact)
- [Faq](https://maymagbiologics.com/faq)
- [Careers](https://maymagbiologics.com/careers)
- [Peptide News](https://maymagbiologics.com/peptide-news)
- [Expertise](https://maymagbiologics.com/expertise)
- [Capabilities](https://maymagbiologics.com/capabilities)
- [Custom Peptides](https://maymagbiologics.com/custom-peptides)
- [All Synthesizers](https://maymagbiologics.com/all-synthesizers)
- [Gmp Production](https://maymagbiologics.com/gmp-production)
- [Oligonucleotide](https://maymagbiologics.com/oligonucleotide)
- [Ai Context](https://maymagbiologics.com/ai-context)
- [Press](https://maymagbiologics.com/press)
- [Media Kit](https://maymagbiologics.com/media-kit)
- [Outreach](https://maymagbiologics.com/admin/outreach)
- [Partners](https://maymagbiologics.com/partners)
- [Other Drug Products](https://maymagbiologics.com/other-drug-products)